At the Bio-IT conference this week, Microsoft introduced Amalga Life Sciences, according to Bio-IT World. Amalga is part of Microsoft's "plan create a single information highway and data aggregation/modeling platform that spans basic research, clinical trials, health care delivery, and consumer health information needs." With this Microsoft will be targeting academic medical centers, biotechs, and pharma. Consider yourself warned.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.